Post by Martin King

👀 𝗩𝗶𝗱𝗲𝗼 𝗣𝗿𝗲𝘃𝗶𝗲𝘄: ⏯ ⏹ ⏮ ⏪ ⏩ in 2:49 minutes 📌 MedTech Leading Voice 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗥𝗼𝘂𝗻𝗱𝘂𝗽 – 𝗠𝗼𝗻𝗱𝗮𝘆, 𝟭𝟱 𝗝𝘂𝗻𝗲 𝟮𝟬𝟮𝟲 𝗗𝗮𝘁𝗮, 𝗔𝗜, 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗮𝗻𝗱 𝗟𝗶𝗳𝗲𝗰𝘆𝗰𝗹𝗲 𝗢𝘃𝗲𝗿𝘀𝗶𝗴𝗵𝘁 𝗮𝗿𝗲 𝗻𝗼𝘄 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗲𝘅𝗽𝗲𝗰𝘁𝗮𝘁𝗶𝗼𝗻𝘀. 💡 𝙊𝙧𝙜𝙖𝙣𝙞𝙨𝙖𝙩𝙞𝙤𝙣𝙨 𝙩𝙝𝙖𝙩 𝙞𝙣𝙫𝙚𝙨𝙩 𝙞𝙣 𝙙𝙞𝙜𝙞𝙩𝙖𝙡 𝙧𝙚𝙖𝙙𝙞𝙣𝙚𝙨𝙨, 𝙚𝙫𝙞𝙙𝙚𝙣𝙘𝙚 𝙦𝙪𝙖𝙡𝙞𝙩𝙮, 𝘼𝙄 𝙜𝙤𝙫𝙚𝙧𝙣𝙖𝙣𝙘𝙚 𝙖𝙣𝙙 𝙡𝙞𝙛𝙚𝙘𝙮𝙘𝙡𝙚 𝙤𝙫𝙚𝙧𝙨𝙞𝙜𝙝𝙩 𝙬𝙞𝙡𝙡 𝙗𝙚 𝙗𝙚𝙨𝙩 𝙥𝙤𝙨𝙞𝙩𝙞𝙤𝙣𝙚𝙙 𝙛𝙤𝙧 𝙛𝙪𝙩𝙪𝙧𝙚 𝙧𝙚𝙜𝙪𝙡𝙖𝙩𝙤𝙧𝙮 𝙨𝙪𝙘𝙘𝙚𝙨𝙨. 🚨 𝗧𝗵𝗶𝘀 𝗪𝗲𝗲𝗸'𝘀 𝗞𝗲𝘆 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗦𝗶𝗴𝗻𝗮𝗹𝘀 🔹 Digital Regulatory Transformation continues to accelerate with European Medicines Agency, Swissmedic, South African Health Products Regulatory Authority and World Health Organization expanding digital platforms, structured data requirements and electronic submissions. 🔹 Advanced Evidence Generation gains momentum as regulators increase acceptance of Real-World Evidence (RWE), biomarkers, external controls and innovative clinical trial methodologies. 🔹 Pharmacovigilance & Lifecycle Compliance remain in focus, with ANVISA strengthening national safety surveillance and reinforcing expectations for signal detection, traceability and continuous monitoring. 🔹 AI Governance & Cybersecurity move further into mainstream regulation as Medicines and Healthcare products Regulatory Agency, European Medicines Agency and European Union Agency for Cybersecurity (ENISA) advance frameworks for AI oversight, SBOM adoption and Cyber Resilience Act readiness. 🔹Team-NB MDR/IVDR Implementation continues to evolve, with increasing scrutiny of clinical evidence, equivalence strategies and transition management for legacy devices. 🔹 Clinical Trial Modernisation advances globally through new risk-based approaches, decentralised trial initiatives, transparency programmes and updated GCP frameworks. 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏Sean Smith, illumino.co, the team at MedTech Leading Voice and Hoodin 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals